US Patent 7700556 Methods of treatment using CTLA4 mutant molecules
Patent 7700556 was granted and assigned to Bristol-Myers Squibb on April, 2010 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 20, 2007
Date of Patent
April 20, 2010
Patent Application Number
11725762
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7700556 Methods of treatment using CTLA4 mutant molecules
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
